Digestery
Everyday supplements › Fish Oil and the Heart › Studies

Opinion or narrative review

Review of what past studies show about EPA and DHA and heart disease

Djuricic and colleagues · Annual review of pharmacology and toxicology · 2023

Original title: Pros and Cons of Long-Chain Omega-3 Polyunsaturated Fatty Acids in Cardiovascular Health.

Under review. A person has not yet checked this summary against the paper. It is written from the PubMed abstract. Until a person checks it, search engines are asked not to list this page.

What the study found

No direction

Long-term studies link higher EPA and DHA to lower heart disease risk. Some large trials support use in high-risk patients, but the evidence is inconsistent. Possible harms are discussed.

The study at a glance

Type of study
Opinion or narrative review
Who or what was studied
general adults and high-risk heart patients, as covered by past studies
What was tested
EPA and DHA from fish, supplements and drugs, as covered by past studies
Who has a stake
No disclosure in PubMed
No disclosure in PubMed.
Journal
Annual review of pharmacology and toxicology, 2023
Source
PubMed record 36662586. This page is based on the abstract only.

How much this study counts

  • –An opinion or narrative review: no new data, and no set method for choosing which studies to discuss.
  • •The PubMed record has no conflict-of-interest statement.
  • •Summarized from the PubMed abstract only. The full paper may hold details the abstract leaves out.

✓ Strength– Limit• Note

These points come from fixed rules about the type of study, its size and length, what it measured, and who has a stake. Every study on Digestery gets the same rules.

Where this study sits

This paper is not on the ladder. It is a opinion or narrative review, and reviews and opinion pieces discuss studies that are already counted on the steps below.

↑ Stronger evidence

  1. Trials in people: heart attacks, strokes and heart deaths

    11

    7 benefit, 4 no difference

  2. Trials in people: other measures

    3

    1 benefit, 2 no difference

  3. Trials in people: lab tests or safety

    0

    None among the papers we read.

  4. Population studies

    0

    None among the papers we read.

  5. Blood levels and genes

    0

    None among the papers we read.

↓ Weaker evidence

  • Points to benefit
  • Mixed
  • No difference
  • No direction
  • Points to harm

How it fits with the other research

The short answer to “Does fish oil prevent heart disease?”

Little or no effect in most trials.

Confidence: moderate. Based on 21 on-topic papers.

Read the full answer
  • Listed with the other papers, but not quoted in the page’s main findings.

Other opinion on this question

See all 21 studies on this question

How this page was made

Label

First read of the abstract
Claude Sonnet
Independent second read
Claude Haiku
Differences settled
The two reads differed. The reviewer checked the abstract and kept the first read. Claude Opus 5.5.
Headline
Claude Sonnet, from the checked study record. A script checked its numbers and wording.
Numbers
Checked against the abstract by a script
“How much this study counts”
Fixed rules, the same for every study
Source check by a person
Not yet. Required before search engines may list this page.

Spot an error? Email a flag with a link to your source, or use the form on the question page.